✦ LIBER ✦

Neuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis

✍ Scribed by Elvira G Jorda; Ester Verdaguer; Anna M Canudas; Andrés Jiménez; Alejandra Bruna; Carme Caelles; Ramona Bravo; Elena Escubedo; David Pubill; Jordi Camarasa; Mercè Pallàs; Antoni Camins

Book ID: 117187678
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 576 KB
Volume: 45
Category: Article
ISSN: 0028-3908
DOI: 10.1016/s0028-3908(03)00204-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

288 Cyclin-dependent kinase inhibitor, f

288 Cyclin-dependent kinase inhibitor, flavopiridol, sensitizes human hepatocelluler carcinoma cells to trail-induced apoptosis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Flavopiridol, a cyclin dependent kinase

Flavopiridol, a cyclin dependent kinase (CDK) inhibitor, induces apoptosis by regulating Bcl-x in oral cancer cells

✍ Mariko Mihara; Satoru Shintani; Koh-ichi Nakashiro; Hiroyuki Hamakawa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 355 KB

Review of flavopiridol, a cyclin-depende

Review of flavopiridol, a cyclin-dependent kinase inhibitor, as breast cancer therapy

✍ Antoinette R. Tan; Sandra M. Swain 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Proteasome inhibitors potentiate leukemi

Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-κB-dependent process

✍ Dai, Yun; Rahmani, Mohamed; Grant, Steven 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 742 KB

Phase II trial of flavopiridol, a cyclin

Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma

✍ Susan Burdette-Radoux; Richard G. Tozer; Reinhard C. Lohmann; Ian Quirt; D. Scot 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 70 KB

Cyclin-dependent kinase inhibitor, flavo

Cyclin-dependent kinase inhibitor, flavopiridol, induces apoptosis and inhibits tumor growth in drug-resistant osteosarcoma and Ewing's family tumor cells

✍ Yan Li; Kazuhiro Tanaka; Xu Li; Takamitsu Okada; Tomoyuki Nakamura; Minoru Takas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 304 KB

## Abstract Multimodal therapies play important roles in the treatment of osteosarcoma (OS) and Ewing's family of tumors (EFTs), two most frequent malignant bone tumors. Although the clinical outcome of primary OS and EFTs is greatly improved, the relapsed cases often are associated with multidrug